KentGRobersonMD

Clinical Trials

• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy Start of enrollment: 2005 Sep 01

  Completed

  Phase 3

• Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy Start of enrollment: 2005 Dec 01

  Completed

  Phase 3

• Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension Start of enrollment: 2007 Dec 01

  Completed

  Phase 3

• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. Start of enrollment: 2008 Apr 01

  Completed

  Phase 3

• A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150) Start of enrollment: 2008 Oct 01

  Completed

  Phase 3

• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia Start of enrollment: 2009 May 01

  Completed

  Phase 3

• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia Start of enrollment: 2009 May 01

  Completed

  Phase 3

• Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES) Start of enrollment: 2010 Apr 23

  Completed

  Phase 3

• BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). Start of enrollment: 2010 Jul 01

  Completed

  Phase 3

• LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Start of enrollment: 2010 Nov 01

  Completed

• Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients Start of enrollment: 2011 Aug 01

  Completed

  Phase 3

• An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia Start of enrollment: 2015 Feb 04

  Completed

  Phase 3

• Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects Start of enrollment: 2014 Dec 11

  Completed

  Phase 2

• Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease Start of enrollment: 2015 Jun 26

  Completed

  Phase 3

• A Multicenter Assessment of ALD403 in Frequent Episodic Migraine Start of enrollment: 2015 Sep 01

  Completed

  Phase 3

• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) Start of enrollment: 2016 Sep 26

  Completed

  Phase 2, Phase 3

• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine Start of enrollment: 2016 Jul 22

  Completed

  Phase 3

• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine Start of enrollment: 2016 Sep 13

  Completed

  Phase 3

• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease Start of enrollment: 2016 Dec 14

  Completed

  Phase 2

• A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Start of enrollment: 2017 Jan 19

  Terminated

  Phase 3

• A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH) Start of enrollment: 2017 Jan 17

  Terminated

  Phase 3

• Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine Start of enrollment: 2016 Nov 01

  Completed

  Phase 3

• A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis Start of enrollment: 2016 Dec 01

  Completed

  Phase 2

• A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) Start of enrollment: 2017 Jan 31

  Active, not recruiting

  Phase 3

• A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs Start of enrollment: 2017 Mar 13

  Completed

  Phase 3

• A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache Start of enrollment: 2017 Apr 27

  Terminated

  Phase 3

• An Efficacy and Safety Study of Fremanezumab in Adults With Migraine Start of enrollment: 2017 Oct 13

  Completed

  Phase 3

• Join now to see all